iCureASPS Supports Three Clinical Projects at the Dana Farber Cancer Institute
Cure Alveolar Soft Part Sarcoma (iCureASPS) is currently supporting three initiatives that hopefully will bring us closer to the day when a cure for Alveolar Soft Part Sarcoma is a reality. Here is a progress report on those projects. 1. The GVAX clinical trial – Opened on January 2006, the first cancer vaccine trial for […]
Stereotactic Radiosurgery (SRS)
Stereotactic Radiosurgery (SRS) is a medical procedure, which is non-invasive surgery to destroy tumors. High dose of ionizing radiation is precisely delivered into a specific area of an organ to kill tumor cells. The beam of radiation is the surgical knife in radiosurgery. The most common forms of ionizing radiation are: proton beams, X-rays and […]
Alveolar Soft Part Sarcoma is a Candidate for Therapy by Drugs that Specifically Inhibit the MET Receptor Tyrosine Kinase
A collaboration between scientists from The Memorial Sloan-Kettering Cancer Center in New York, Dana-Farber Cancer Institute in Boston and The Johns Hopkins Hospital in Baltimore reveals a new therapeutic target in Alveolar Soft Part Sarcoma. The results of that collaboration were recently published in the scientific Journal Cancer Research volume 67 pages 919-929, 2007. The […]
Two Sorafenib (Nexavar) Clinical Trials are Currently Recruiting Sarcoma Patients in Different Locations Across the USA
1. Phase II Study of Sorafenib in Patients With Advanced Soft Tissue Sarcomas 2. Sorafenib in Treating Patients With Soft Tissue Sarcomas Alveolar Soft Part Sarcoma (ASPS) is highly angiogenic: it involves intensive growth of new blood vessels into the tumor. Those blood vessels connect the tumor to the blood system, supply oxygen and nutrients […]
In Loving Memory of Matthew Scott Pinson (ASPS patient) 2/21/85 – 7/27/04
Join us in our fight against Alveolar Soft Part Sarcoma (ASPS) by sponsoring runner Danna Quinn in the “P.F. Chang’s Rock’n Roll” Marathon & Half Marathon on January 14th, 2006 in Phoenix, AZ. Contributions are tax deductible. Danna Quinn, mother of Matt will be running the half marathon in memory of her beloved son and […]
Alveolar soft-part sarcoma: scientific review and update / November 2006
Written by Folpe AL and Deyrup AT at the Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Minnesota, USA. Alveolar soft-part sarcoma (ASPS) is a rare, distinctive sarcoma, typically occurring in young patients. Although it displays a relatively indolent clinical course, the ultimate prognosis is poor and is often characterised by late metastases. Recently, […]
“Cure Alveolar Soft Part Sarcoma International” (iCureASPS) transfers funds to support projects in two institutions where research is done to find a cure for ASPS
I am very pleased to inform you that “Cure Alveolar Soft Part Sarcoma International” has transferred 37,429 dollars to support the research and clinical trial which are currently held at the Dana Farber Cancer Institute in Boston. “Team ASPS” rode in the August 2006 PMC bike ride and collected those funds. Since 2004, our team […]
Update on the Clinical Trial for Alveolar Soft Part Sarcoma at the Dana Farber Cancer Institute in Boston
October 11, 2006 The clinical trial “GVAX Cancer Vaccine” started in January 2006 and enrollment is still open to new patients. So far 11 patients were selected to participate in the trial. Eight of those patients have the diagnosis of Alveolar Soft Part Sarcoma (ASPS). All the eight ASPS patients have completed the study. There […]